logoSign upLog in
Alan Lu

Alan Lu

To Sales and other hives 24/02/2016

In 2015, China’s pharmaceutical industry experienced a slowdown in its growth, which can be attributed to the increasingly rigid governmental supervision and more and more fierce competition. However, a slowdown in growth doesn’t indicate industry decline, but it is an opportunity of transformation and upgrading for the overall pharmaceutical industry instead, according to CCM.

CCM,Data & Business Intelligence
CCM,Data & Business Intelligence
www.cnchemicals.com
Relevant